Jan 03, 2020 7:00am EST New Data From Hadassah Medical Center Lab Show Can-Fite’s Namodenoson Induces Weight Loss
Dec 26, 2019 7:00am EST Golan Bitton Univo Pharmaceutical CEO Elected to the Can-Fite Board: A Strategic Partnership with Univo to Develop Cannabinoid-Based Products is Ongoing
Dec 05, 2019 7:00am EST Can-Fite to Attend BioFIT 2019 Conference in Europe with Focus on Partnering Meetings for Namodenoson in NASH
Nov 29, 2019 7:00am EST Can-Fite Reports Third Quarter 2019 Financial Results & Provides Clinical Update
Nov 21, 2019 7:00am EST Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on November 25, 2019
Nov 11, 2019 7:00am EST Can-Fite Granted U.S. Patent for Piclidenoson in the Treatment of Osteoarthritis, Positioning this Indication for Animal Health Market
Nov 04, 2019 7:00am EST Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients
